Various Indoor and Outdoor Sites - Technical Grade Active Ingredients: Data Requirements for Use Site Category (USC # 31)

Various Indoor and Outdoor Sites - Technical Grade Active Ingredients

Data Requirements for Use Site Category ( USC # 31): Various Indoor and Outdoor Sites - TGAI
Data Code Title Data required Conditions Volume No and Pages
0 Index R    
1 Label R    
2 Chemistry requirements for the registration of a technical grade of active ingredient (TGAI) or an integrated system product.      
2.1 Applicant's Name and Office Address R    
2.2 Manufacturer's Name and Office Address and Manufacturing Plant's Name and Address R    
2.3 Product Trade Name R    
2.3.1 Other Names R    
2.4 Common Name R    
2.5 Chemical Name R    
2.6 Chemical Abstracts Registry Number R    
2.7 Structural Formula R    
2.8 Molecular Formula R    
2.9 Molecular Weight R    
2.11 Manufacturing Methods for the TGAI      
2.11.1 Manufacturing Summary R    
2.11.2 Description of Starting Materials R    
2.11.3 Detailed Production Process Description R    
2.11.4 Discussion of Formation of Impurities R    
2.12 Specifications      
2.12.1 Establishing Certified Limits R    
2.12.2 Control Product Specification Form R    
2.13 Preliminary Analysis      
2.13.1 Methodology/Validation R    
2.13.2 Confirmation of Identity R    
2.13.3 Batch Data R    
2.13.4 Impurities of Toxicological Concern CR If applicable  
2.14 Chemical and Physical Properties      
2.14.1 Colour R    
2.14.2 Physical State R    
2.14.3 Odour R    
2.14.4 Melting Point / Melting Range R Solid at room temperature  
2.14.5 Boiling Point / Boiling Range R Liquid at room temperature  
2.14.6 Density or Specific Gravity R See 8.2.1  
2.14.7 Water Solubility (mg/L) R See 8.2.1  
2.14.8 Solvent Solubility (mg/L) R    
2.14.9 Vapour Pressure R See 8.2.1  
2.14.10 Dissociation Constant R See 8.2.1  
2.14.11 Octanol/Water Partition Coefficient R See 8.2.1  
2.14.12 UV/Visible Absorption Spectra R See 8.2.1  
2.14.13 Stability (Temperature, Metals) R    
2.14.14 Storage Stability Data CR Required for integrated system products  
2.15 Sample(s) of Analytical Standards and ROC R    
2.16 Other Studies/Data/Reports CR If available  
4 Toxicology      
4.1 Summaries R    
4.2 Acute Studies - TGAI      
4.2.1 Acute Oral R    
4.2.2 Acute Dermal R    
4.2.3 Acute Inhalation R    
4.2.4 Primary Eye Irritation R    
4.2.5 Primary Dermal Irritation R    
4.2.6 Dermal Sensitization R    
4.2.7 Potentiation/Interaction CR If available  
4.2.8 Antidote CR If available  
4.2.9 Other Acute Studies CR If available  
4.3 Short-term Studies - TGAI      
4.3.1 Short-term Oral (90-day rodent) R    
4.3.2 Short-term Oral (90-day and/or 12-month dog) CR If available  
4.3.3 Short-term Oral (28-day) CR If available  
4.3.4 Short-term Dermal (90-day) CR If available  
4.3.5 Short-term Dermal (21/28-day) R    
4.3.6 Short-term Inhalation (90-day) CR Required if there is the likelihood of significant repeated inhalation exposure to the product as a gas, vapor or aerosol  
4.3.7 Short-term Inhalation (21/28-day) CR If available  
4.3.8 Other Short-term Studies CR If available  
4.4 Long-term Studies - TGAI      
4.4.1 Chronic (rodent) R 4.4.1 and 4.4.2 could be submitted as a combined study under 4.4.4  
4.4.2 Oncogenicity (rodent species 1) R 4.4.1 and 4.4.2 could be submitted as a combined study under 4.4.4  
4.4.3 Oncogenicity (rodent species 2) R    
4.4.4 Combined Chronic/Oncogenicity (rodent) CR 4.4.1 and 4.4.2 could be submitted as a combined study under 4.4.4  
4.4.5 Other Long-term Studies CR If available  
4.5 Special Studies - TGAI      
4.5.1 Multigeneration Reproduction (rodent) R    
4.5.2 Prenatal Developmental Toxicity (rodent) R    
4.5.3 Prenatal Developmental Toxicity (non-rodent) R    
4.5.4 Genotoxicity: Bacterial Reverse Mutation Assay R    
4.5.5 Genotoxicity: In vitro Mammalian Cell Assay R    
4.5.6 Genotoxicity: In vitro Mammalian Clastogenicity CR Required if not addressed in study submitted for 4.5.5  
4.5.7 Genotoxicity: In vivo Cytogenetics R    
4.5.8 Other Genotoxicity Studies CR If available  
4.5.9 Metabolism/Toxicokinetics in Mammals (laboratory animals) R    
4.5.10 Acute Delayed Neurotoxicity (hen) CR Required if the test substance is an organophosphorus substance or is structurally related to other substances that may cause delayed neurotoxicity  
4.5.11 28-day Delayed Neurotoxicity (hen) CR Required if results of acute delayed neurotoxicity study indicates effects, or if other available data indicate the potential for this type of delayed neurotoxicity  
4.5.12 Acute Neurotoxicity (rat) CR Required if there is neurotoxic potential  
4.5.13 90-day Neurotoxicity (rat) CR Required if there is neurotoxic potential  
4.5.14 Developmental Neurotoxicity CR Required if neurological effects are observed in other studies
Should be considered if test substance:
i) causes neuropathology or neurotoxicity in adults;
ii) is hormonally active in vivo; or
iii) causes other types of nervous system involvement at a developmental stage
 
4.8 Other Studies/Data/Reports CR If available  
8 Environmental Chemistry and Fate      
8.1 Summaries R    
8.2 Laboratory Studies      
8.2.1 Summary of Physicochemical Properties to Include, Solubility in Water, Vapour Pressure, Octanol:Water Partition Coefficient, Dissociation Constant, UV-Visible Absorption, Density or Specific Gravity (See parts 2 and 3) R See 2.14.7, 2.14.9, 2.14.11, 2.14.10, 2.14.13, 2.14.6, and 3.5.6  
8.2.2 Analytical Methodology (parent compound and transformation products)      
8.2.2.1 Soil CR If there is a potential for soil exposure  
8.2.2.2 Sediment CR If there is a potential for aquatic exposure  
8.2.2.3 Water CR See 8.2.2.2  
8.2.2.4 Biota R    
8.2.3 Laboratory Studies of Transformation      
8.2.3.1 Summary R    
8.2.3.2 Hydrolysis R    
8.2.3.4 Biotransformation in Soil (TGAI)      
8.2.3.4.2 Aerobic Soil 20°-30°C CR If there is a potential for soil exposure  
8.2.3.5 Biotransformation in Aquatic Systems (TGAI)      
8.2.3.5.2 Aerobic Water 20°-30°C CR If there is a potential for aquatic exposure.  
8.2.3.6 Special Studies Related to Use-Pattern or Formulation (EP) CR    
8.2.4 Laboratory Studies of Mobility      
8.2.4.1 Summary CR    
8.4 Storage, Disposal and Decontamination (TGAI or EP)      
8.4.1 Summary R    
8.5 Other Environmental Fate Studies (TGAI or EP)      
8.5.1 Summary CR Based on concerns arising from results of other studies  
8.6 Other Studies/Data/Reports CR If available  
9 Environmental Toxicology      
9.1 Summary CR    
9.3 Non-Target Freshwater Invertebrates      
9.3.1 Summary CR    
9.3.2 Daphnia sp. Acute CR If there is a potential for freshwater exposure  
9.3.3 Daphnia sp. Chronic (Life-Cycle) CR Most sensitive (i.e., one of) daphnid (9.3.3); marine crustacean or estuarine/marine mollusk (9.4.5); or fish (9.5.3.1), where there is concern based on acute effects, persistence, potential for exposure or frequency of application  
9.3.4 Laboratory Studies with Other Species CR If there is a potential for exposure  
9.5 Fish      
9.5.1 Summaries CR    
9.5.2 Acute Studies      
9.5.2.1 Cold Water Fish (rainbow trout) CR If there is a potential for freshwater exposure  
9.5.2.2 Warm Water Fish (bluegill sunfish) CR See 9.5.2.1  
9.5.2.3 Other Freshwater Fish Species CR If there is a potential for exposure  
9.5.3 Sublethal and Chronic Studies      
9.5.3.1 Fish, Early Life Cycle Tox. Test CR Most sensitive (i.e., one of) daphnid (9.3.3); marine crustacean or estuarine/marine mollusk (9.4.5); or fish (9.5.3.1), where there is concern based on acute effects, persistence, potential for exposure or frequency of application  
9.5.3.2 Fish, Life Cycle Tox. Test CR Where there is concern based on acute effects, persistence, potential for exposure or frequency of application  
9.5.6 Bioaccumulation CR If there is a potential for exposure and log Kow is greater than or equal to 3  
9.6 Wild Birds      
9.6.1 Summary CR    
9.6.2 Acute Studies      
9.6.2.1 Oral (LD50) Bobwhite Quail CR If there is a potential for avian exposure, one of 9.6.2.1 or 9 .6.2.2  
9.6.2.2 Oral (LD50) Mallard Duck CR See 9.6.2.1  
9.6.2.3 Oral (LD50) Other Species CR If avian acute oral toxicity is of concern and there is a potential for exposure  
9.6.2.4 Dietary (LC50) Bobwhite Quail CR If there is a potential for avian exposure  
9.6.2.5 Dietary (LC50) Mallard Duck CR See 9.6.2.4  
9.6.2.6 Dietary (LC50) Other Species CR If avian acute dietary toxicity is of concern and there is a potential for exposure.  
9.6.3 Chronic Studies      
9.6.3.1 Avian Reproduction Bobwhite Quail CR Triggered by acute effects, persistence, bioconcentration potential, mammalian reproductive effects, potential for exposure or frequency of application  
9.6.3.2 Avian Reproduction Mallard Duck CR See 9.6.3.1  
9.6.3.3 Avian Reproduction Other Species CR See 9.6.3.1  
9.6.6 Special Studies Related to the Intended Use-Pattern (TGAI or EP) CR See 9.6.5  
9.7 Wild Mammals      
9.7.1 Summary CR Based on concerns arising from results of other studies  
9.8 Non-Target Plants      
9.8.1 Summary CR    
9.8.2 Fresh Water Algae CR If there is potential for freshwater exposure  
9.8.3 Marine Algae      
9.8.4 Terrestrial Vascular Plants CR If there is a potential for exposure  
9.8.5 Aquatic Vascular Plants CR 9.8.4  
9.9 Other Studies/Data/Reports CR If available  
12.5 Foreign Reviews      
12.5.2 Foreign Reviews of Chemistry Requirements for TGAIs or Integrated System Products      
12.5.4 Foreign Reviews of Toxicology      
12.5.8 Foreign Reviews of Environmental Chemistry and Fate      
12.5.9 Foreign Reviews of Environmental Toxicology      
12.5.10 Foreign Reviews of Value      
12.7 Comprehensive Data Summaries      
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: